CLAIRYG Trademark

Trademark Overview

On Friday, April 15, 2011, a trademark application was filed for CLAIRYG with the United States Patent and Trademark Office. The USPTO has given the CLAIRYG trademark a serial number of 79098073. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, April 16, 2021. This trademark is owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES. The CLAIRYG trademark is filed in the Pharmaceutical Products category with the following description:

Polyvalent human immunoglobulin to be administered parenterally, subcutaneously or intravenously, by health care workers in hospitals and clinics, in outpatient clinics and during external consultations, in medical practices and by self-administration for the treatment of congenital or acquired immunodeficiencies or to provide immunomodulation
clairyg

General Information

Serial Number79098073
Word MarkCLAIRYG
Filing DateFriday, April 15, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, April 16, 2021
Registration Number4140807
Registration DateTuesday, May 15, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2012

Trademark Statements

Goods and ServicesPolyvalent human immunoglobulin to be administered parenterally, subcutaneously or intravenously, by health care workers in hospitals and clinics, in outpatient clinics and during external consultations, in medical practices and by self-administration for the treatment of congenital or acquired immunodeficiencies or to provide immunomodulation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 21, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Wednesday, November 3, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Wednesday, November 3, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, April 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 8, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, April 3, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 4, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, September 5, 2019GENERIC MADRID TRANSACTION SENT TO IB
Thursday, September 5, 2019GENERIC MADRID TRANSACTION CREATED
Wednesday, August 21, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 21, 2018CANCELLED SECTION 71
Monday, May 15, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, March 27, 2015NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 21, 2014NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 4, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 5, 2013FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, February 5, 2013FINAL DISPOSITION PROCESSED
Sunday, November 25, 2012NOTIFICATION PROCESSED BY IB
Wednesday, August 15, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 15, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, February 28, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 8, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 8, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 25, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 25, 2012ASSIGNED TO LIE
Friday, January 6, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 8, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 8, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 8, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 23, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 23, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, August 13, 2011REFUSAL PROCESSED BY IB
Thursday, July 28, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 28, 2011REFUSAL PROCESSED BY MPU
Thursday, July 28, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 27, 2011NON-FINAL ACTION WRITTEN
Friday, July 22, 2011ASSIGNED TO EXAMINER
Friday, July 1, 2011APPLICATION FILING RECEIPT MAILED
Monday, June 27, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 24, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

clairyg clinics self practices medical administration consultations treatment provide immunomodulation immunodeficiencies